Walgreen's Same-Store Sales Dive

pillsDrug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to the impact of generic drug sales replacing sales of higher-priced brand-name drugs. Total sales fell 3.9% from $6.09 billion last year to $5.85 billion.

Pharmacy sales in November fell 4.7%, and same-store pharmacy sales fell 8.8%. Pharmacy sales accounted for 63.2% of monthly sales.

Walgreen did not specifically indicate any impact from its now-resolved dispute with Express Scripts Inc. (NASDAQ: ESRX). During the nine-month fight with Express Scripts, Walgreen's lost millions of customers, and as much as 60% of the total could be gone permanently to competitor CVS Caremark Corp. (NYSE: CVS). Walgreen did say that prescriptions filled at comparable stores fell by 2.9% in November following a 1.8% drop in October.

Walgreen stock is up 2.45% this morning, at $35.12 in a 52-week range of $28.53 to $37.35, even though virtually every metric reported today was down. Even the number of flu shots administered is lower this year.

Paul Ausick


Filed under: 24/7 Wall St. Wire, Retail, Services Tagged: CVS, ESRX, WAG
Read Full Story

Markets

DJIA 25,162.41 -137.51 -0.54%
NASDAQ 7,774.12 -96.78 -1.23%
NIKKEI 225 21,937.81 -266.41 -1.20%
HANG SENG 27,323.59 0.00 0.00%
DAX 12,163.01 -195.86 -1.58%
USD (per EUR) 1.13 0.00 -0.01%
USD (per CHF) 0.99 0.00 0.06%
JPY (per USD) 110.58 0.01 0.01%
GBP (per USD) 1.27 0.00 -0.01%